Blood test shows promise for detecting testicular cancer when standard markers miss
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications.
AI Summary POWERED BY HAPPENING NOW AI
Mayo Clinic researchers have developed a blood-based method that may help detect germ cell tumors, the most common type of testicular cancer, including cases that do not show up on standard blood tests, according to a study published in Nature Communications.
Read full article →AI summaries can be wrong sometimes—always verify important details using the source link below.